Somatic Symptom and Functional Disorders: Types, Diagnosis, and Treatment
Author: Angela Bogdanova · Published: October 12, 2026 · Editorial Policy
Research cluster: Somatic Symptom & Functional Disorders · Written by Artificial Sapiens
Somatic symptom and functional disorders describe a clinically important group of presentations in which physical symptoms, bodily distress, illness concerns, or altered movement, sensation, and seizure-like episodes affect daily life. The terms span several distinct diagnoses as well as broader symptom descriptions. A person may have an established medical disease, a functional neurological condition, a mental health condition, several conditions together, or symptoms still requiring evaluation. Accurate care begins by determining which situation applies.
This clinical guide explains the major diagnostic families, how physicians and psychologists assess them, which treatments have evidence, and when symptoms require urgent attention. It uses the American Psychiatric Association's DSM-5-TR and the World Health Organization's ICD-11 as separate classification systems. Neither the reality of a symptom nor the seriousness of impairment depends on whether routine tests detect a structural abnormality. [DSM-5-TR chapter] [WHO ICD-11 clinical guidance]
What are somatic symptom and functional disorders?
A somatic symptom is a bodily experience such as pain, fatigue, nausea, breathlessness, weakness, dizziness, palpitations, or altered sensation. Somatic distress refers to the suffering, concern, functional limitations, or disruption associated with such experiences. These descriptions are not diagnoses. A persistent physical symptom generally means that a bodily complaint continues for months or recurs over time; it may have a recognized medical cause, multiple contributing processes, or an uncertain cause. [Lancet review of persistent physical symptoms]
Somatic symptom disorder (SSD) is a specific DSM-5-TR mental disorder involving one or more distressing physical symptoms together with excessive symptom-related thoughts, feelings, or behaviors. Illness anxiety disorder (IAD) centers on a preoccupation with having or developing a serious illness, usually with absent or mild somatic symptoms. Functional neurological disorder (FND) involves symptoms of altered voluntary motor or sensory function accompanied by positive clinical findings demonstrating incompatibility with recognized neurological disease patterns. These conditions require different diagnostic judgments, even when they overlap.
The umbrella phrase 'somatic symptom and functional disorders' is useful for organizing related clinical education, but it is not a single diagnosis with one universal diagnostic test or treatment plan. 'Functional' has different technical meanings across specialties. A functional neurological symptom should not be treated as evidence that all bodily symptoms are psychiatric, and a diagnosis of SSD does not automatically establish FND. Modern care integrates general medicine, neurology, psychiatry, psychology, and rehabilitation according to the person's presentation.
The main types and how they differ
Somatic symptom disorder (SSD)
SSD may involve persistent pain, gastrointestinal symptoms, fatigue, breathing discomfort, or a changing combination of physical complaints. In DSM-5-TR the central clinical issue is the pattern of distress and excessive health-related responses surrounding symptoms. Examples include sustained catastrophic interpretation of bodily sensations, unusually high health anxiety, and extensive time and energy devoted to symptoms or health concerns. Clinicians consider severity, duration, social context, disability, and whether the reactions are disproportionate to the situation.
An independently diagnosed medical disease can coexist with SSD. For example, someone may have a documented inflammatory condition and, separately, an unusually pervasive cycle of worry, checking, and symptom-related impairment. A person with persistent or unexplained pain does not meet SSD criteria simply because tests are inconclusive. Establishing the mental disorder requires a positive assessment of its own criteria, appropriate cultural and clinical context, and medical evaluation. [American Psychiatric Association classification]
Illness anxiety disorder and broader health anxiety
Health anxiety is a dimensional experience that ranges from temporary, proportionate worry to persistent, impairing preoccupation. It may increase after a frightening medical event, family illness, ambiguous test results, or exposure to alarming health information. Illness anxiety disorder is the DSM diagnosis considered when preoccupation with having or acquiring a serious illness persists, bodily symptoms are absent or relatively mild, health anxiety is high, and checking or avoidance occupies substantial attention. A clinician evaluates duration, alternative explanations, and functional consequences.
SSD and IAD can share reassurance seeking, internet searching, frequent appointments, or avoidance of health care. The diagnostic focus differs: SSD generally concerns distressing bodily symptoms and the person's response to them, while IAD generally centers on fears of serious disease despite few or mild symptoms. Obsessive-compulsive disorder may involve intrusive illness obsessions and compulsions; panic disorder may involve sudden surges of fear and physiological arousal. The relationship between illness anxiety and OCD deserves condition-specific assessment. [Published English Hub clinical comparison: OCD and illness anxiety]
Functional neurological disorder (FND)
FND, also called functional neurological symptom disorder or, in DSM terminology, conversion disorder, includes disturbances of movement, strength, walking, sensation, speech, or episodes resembling seizures. Symptoms reflect altered nervous-system functioning and can cause severe disability. The diagnosis is made by a clinician who identifies context-appropriate positive signs of functional neurological dysfunction, evaluates other neurological and medical explanations, and considers coexistence with neurological disease.
For functional limb weakness, a neurologist may find an internally inconsistent movement pattern, such as a meaningful change in hip-extension strength during the Hoover sign. In some functional tremors, the tremor changes frequency or diminishes when the person rhythmically moves another limb, called entrainment or distractibility. Such signs have specific uses and limitations: they require trained examination, cannot be reduced to a home test, and do not make a normal scan alone diagnostic. The absence of a particular sign does not settle every case. [BMJ clinical review] [2025 practical management review]
Functional seizures (formerly PNES)
Functional seizures are episodes of altered awareness, responsiveness, movement, or sensation that can resemble epileptic seizures. The older term psychogenic nonepileptic seizures, abbreviated PNES, is still common in research and medical records. A clinical evaluation considers eyewitness history, characteristic episode features, smartphone videos when available, neurological examination, and video electroencephalography (video-EEG) of typical events when feasible. Some people have both functional seizures and epilepsy, so an established functional seizure diagnosis does not eliminate the possibility of epileptic events.
The 2026 American Academy of Neurology guideline recommends careful assessment for co-occurring epilepsy and mental health conditions and supports psychological interventions that may improve several outcomes. It also advises against prescribing antiseizure medicines or benzodiazepines solely for functional seizures without another indication. Anyone already taking a prescribed medicine should discuss the diagnosis and any change or taper with the treating clinician; stopping it independently can be dangerous. [American Academy of Neurology 2026 guideline]
Functional movement, sensory, speech, and cognitive presentations
Functional movement disorders may involve tremor, dystonia-like postures, jerks, weakness, or gait disturbance. Functional sensory symptoms can include altered touch, tingling, or loss of sensation; functional speech or voice symptoms can include changes in fluency or speech production. Some individuals also describe fatigue, pain, sleep disruption, and problems concentrating. Each presentation has neurological differentials, and treatment selection should reflect the actual symptoms and examination.
Functional cognitive disorder (FCD) describes cognitive complaints, often memory or concentration difficulties, associated with a characteristic pattern of internal inconsistency between reported difficulties and aspects of observed performance. It is an evolving clinical construct rather than an independent, universally established DSM-5-TR diagnosis. Proposed diagnostic criteria require further validation. Clinicians must evaluate sleep, medication effects, mood, neurological disease, sensory limitations, and possible neurodegenerative disorders rather than assume that subjective memory complaints are functional. [2023 systematic review and meta-analysis] [2025 international Delphi study]
Bodily distress disorder in ICD-11
The World Health Organization's ICD-11 includes bodily distress disorder (BDD) as a diagnostic category centered on bodily symptoms that are distressing and receive excessive attention, with related impairment and persistence requirements. The meaning of 'excessive' must be considered against clinical circumstances, including existing illnesses. Although the ICD-11 construct overlaps with DSM-5-TR somatic symptom disorder, the operational criteria and classification context differ. Terms should be recorded with the classification system used rather than treated as interchangeable codes.
Research comparing the systems finds that they identify overlapping but nonidentical patient groups. A 2025 comparison reported different case frequencies for ICD-11 BDD and DSM-5 SSD within its study settings; those figures should not be generalized as universal population prevalence. ICD-11 hypochondriasis and dissociative neurological symptom disorder likewise have different locations in the classification architecture from their DSM counterparts. [WHO ICD-11 clinical descriptions] [Cross-classification study]
Psychological factors affecting other medical conditions
DSM-5-TR separately describes psychological factors affecting other medical conditions when psychological or behavioral factors adversely influence an established medical condition, for example by interfering with adherence or increasing a medically relevant risk. This diagnosis depends on demonstrating that relationship within clinical criteria. It differs from SSD, which evaluates symptom-related distress and response, and from general observations that stress can affect sleep, pain, or well-being. The underlying disease continues to require disease-specific medical treatment. [DSM-5-TR diagnostic framework]
Factitious disorder, malingering, and intentionality
Factitious disorder involves an identified pattern of falsification or induction of illness-related signs or symptoms associated with presenting oneself or another person as ill, in the absence of obvious external rewards. Malingering is the intentional production or exaggeration of symptoms for external incentives and is a clinical or forensic consideration rather than equivalent to a psychiatric disorder diagnosis. Deliberate deception cannot be inferred from unusual symptoms, inconsistent examination findings, disability claims, poor treatment response, or a clinician's frustration. These issues demand careful independent evidence and safeguarding where relevant.
Functional neurological disorder, SSD, and illness anxiety disorder do not require intentional symptom creation. Conflating them with factitious disorder harms patients and undermines clinical assessment. Concerns about imposed illness affecting a child or dependent person require appropriate medical, safeguarding, and professional procedures rather than accusation by an unqualified observer.
DSM-5-TR and ICD-11: why classification matters
DSM-5-TR groups SSD, IAD, conversion disorder/FND, factitious disorder, psychological factors affecting other medical conditions, and specified or unspecified related conditions within somatic symptom and related disorders. ICD-11 arranges its corresponding clinical problems differently, including bodily distress disorder among mental and behavioral diagnoses, hypochondriasis within obsessive-compulsive or related disorders, and dissociative neurological symptom disorder within dissociative disorders. Clinical services may use a diagnostic name from one system while billing or coding under another.
A diagnostic label should therefore be accompanied by the exact classification and criteria applied. SSD is not an exact synonym of BDD; DSM conversion disorder/FND and ICD dissociative neurological symptom disorder should be mapped with attention to the patient's presentation; and 'health anxiety' is a descriptive term that does not by itself establish IAD. Professionals should verify local coding and current updates instead of assuming that names map one-to-one between systems. [DSM-5-TR] [WHO ICD-11 CDDR]
What symptoms can occur?
Patients may report pain in one or several body regions, recurrent abdominal discomfort, nausea, altered bowel habits, exhaustion, dizziness, racing heart, shortness of breath, headaches, sleep difficulty, tingling, weakness, tremor, altered walking, sensory disturbance, speech changes, non-epileptic seizure-like episodes, or memory and attention complaints. The same symptom can occur in a cardiovascular, neurological, endocrine, inflammatory, gastrointestinal, medication-related, functional, psychiatric, or mixed condition. Symptom type alone does not identify its cause.
For SSD, the functional and emotional response to physical symptoms is diagnostically important. For IAD, preoccupation with serious illness is more central than symptom intensity. For FND, a context-sensitive pattern of motor or sensory dysfunction and clinical signs is central. Some individuals experience substantial symptom variation across time or situations. Variation is itself a clinical observation, not proof of volitional control.
A high-quality history documents onset, evolution, duration, triggers, illness or injury preceding symptoms, severity, interference with work or education, sleep, medication exposure, previous diagnoses, and what makes daily functioning better or worse. It also asks what the person fears, how they interpret symptoms, what care they have already received, and which treatment goals matter to them. This is relevant whether a medical cause is known or remains uncertain.
How are these conditions diagnosed?
Step 1: identify urgent problems and assess the symptoms medically
The first duty is to evaluate symptoms for immediate medical risk. A clinician considers vital signs and focused examination, timing and severity, and whether urgent testing is necessary. New sudden weakness or facial droop, speech difficulty, severe new headache, sustained chest pain, major breathing difficulty, fainting with concerning features, or a first seizure-like event may require emergency assessment. A previous diagnosis of FND or SSD must never become a blanket explanation for a new symptom.
The next step is proportionate investigation guided by history, examination, red flags, age, medical history, and clinical guidelines. Appropriate tests can include laboratory studies, cardiovascular evaluation, neurological examination, imaging, electroencephalography, or targeted specialist assessment. Testing is selected for a clinical reason rather than repeated without a plan. Physicians should explain both what test results show and what uncertainty remains.
Step 2: use positive diagnostic criteria, not unsupported assumptions
SSD is evaluated against DSM-5-TR criteria involving distressing somatic symptoms and excessive thoughts, feelings, or behaviors; the symptomatic state is persistent, typically for more than six months even when an individual symptom fluctuates. IAD involves persistent illness preoccupation and associated health anxiety or checking/avoidance, generally for at least six months, while feared diseases may change. A screening scale showing a high symptom burden or health anxiety is a prompt for conversation, not a diagnosis.
FND requires signs of incompatibility or internal inconsistency appropriate to the subtype and clinical setting, as established through professional neurological examination. The exact tests for functional weakness, tremor, gait, speech, and seizure-like events differ. Clinicians record the positive observations in the report and explain them in understandable terms. Normal imaging, nonspecific stress history, or merely failing to find another diagnosis cannot replace that examination. [FND diagnosis and management review] [Practical FND review]
Step 3: examine differentials and coexisting conditions
Differential diagnosis means determining which other disorders could explain the presentation and whether more than one condition is present. For pain and fatigue, possibilities may include inflammatory disorders, sleep conditions, endocrine problems, neuropathies, medication effects, mood disorders, and organ-specific disease. For weakness or altered gait, stroke, demyelinating disorders, neuromuscular conditions, vestibular syndromes, spinal disease, and medication effects can matter. For seizure-like events, epilepsy, syncope, metabolic changes, movement disorders, and some sleep disorders may require consideration.
The presence of anxiety or depression does not establish the origin of physical symptoms. Likewise, a known medical illness does not exclude secondary health anxiety or SSD. Neurodevelopmental characteristics, adverse treatment experiences, and cultural beliefs can influence how distress is expressed and discussed; none substitutes for a diagnostic criterion. Clinicians revisit the formulation when the symptom pattern changes or treatment fails.
Step 4: assess functioning, distress, and the person's priorities
A complete assessment covers independence, employment or school attendance, mobility, relationships, sleep, health-related quality of life, and practical needs. Scales such as the Patient Health Questionnaire-15 (PHQ-15), Somatic Symptom Scale-8 (SSS-8), or measures of health anxiety may quantify symptoms or track changes in the right context; they do not independently determine SSD, FND, or IAD. Cognitive testing and video-EEG also have different functions and require specialist interpretation.
Shared documentation can prevent repeated consultations from becoming fragmented. A useful clinical summary identifies established diagnoses, tests already performed and their limitations, new issues requiring reassessment, helpful strategies, referral responsibilities, and agreed follow-up intervals. When a specialist makes a positive FND diagnosis, the treating team should explicitly preserve a pathway for new neurological or medical symptoms.
What causes persistent bodily distress or functional symptoms?
There is no single verified mechanism that explains every condition in this group. Medical disease, inflammation, injury, infection, sleep disturbance, autonomic changes, pain-processing changes, adverse drug effects, emotional distress, attentional processes, symptom expectations, learning, and social circumstances may all contribute in different combinations. A clinical formulation describes evidence relevant to a specific person rather than applying a universal story about psychological causation.
For persistent physical symptoms, contemporary reviews discuss interactions between bodily processes and perception, symptom attention, threat appraisal, expectations, avoidance, and health care experiences. Interoception refers to the detection and interpretation of internal bodily signals. Amplified attention to a sensation can increase its salience and perceived urgency, particularly under uncertainty. These processes can occur in people with recognized medical diseases as well as in those without a settled medical explanation. [Lancet integrative review] [Published English Hub article on interoception]
In FND, research examines altered attention, agency, expectation, emotion–motor interaction, and network-level processes. Such models can illuminate testable hypotheses and treatment approaches, but neuroimaging associations and predictive-processing explanations do not supply a diagnostic biomarker or establish the cause of an individual's symptoms. A functional symptom may begin after injury, infection, emotional shock, physical exertion, or with no clear precipitating event. Trauma exposure is reported in some groups, but it is neither universal nor required for FND diagnosis.
Psychological trauma, dissociation, anxiety, and depression may be clinically important comorbidities or contributors in selected cases. Treatment can address them when present. Clinicians should avoid converting a statistical association into a claim that the patient's symptoms must reflect a hidden trauma. The available evidence supports personalized assessment of predisposing, precipitating, and perpetuating factors without treating any one factor as an explanation for all patients. [FND practical clinical review] [Published English Hub article on PTSD's physical symptoms]
How are somatic symptom and functional disorders treated?
An effective plan identifies the specific diagnosis, coexisting medical illness, functional goals, treatment preferences, available services, and response over time. The most important shared elements are a clear and respectful explanation, clinically appropriate medical follow-up, coordinated treatment of established diseases, and an approach that supports functioning. A diagnosis can open access to active treatment while allowing clinicians to reassess when new evidence emerges.
Communication, medical continuity, and shared care
Patients benefit when clinicians name the positive findings supporting a diagnosis, explain why symptoms feel real and disabling, and discuss which interventions target which difficulties. Saying that symptoms are caused by imagination or are simply stress-related undermines assessment. A primary care clinician may help coordinate scheduled follow-up and appropriate referrals while keeping acute red flags visible. Regular planned appointments can reduce crisis-driven fragmentation while maintaining access to medically indicated investigation.
Treatment plans should include goals such as returning to school, walking more safely, reducing disruptive checking, improving sleep, or participating in valued activities. Functional improvements sometimes precede a substantial reduction in symptoms. The person should be able to review the plan, report adverse effects, and receive a revised evaluation when symptoms evolve.
Psychotherapy for SSD and illness anxiety
Cognitive behavioral therapy (CBT) has a meaningful evidence base for distressing persistent physical symptoms and health anxiety, with average benefits varying by condition, comparison treatment, and outcome. CBT can address catastrophic interpretations, reassurance rituals, activity avoidance, heightened symptom monitoring, and patterns that maintain distress. This is treatment for identifiable cognitive, emotional, and behavioral processes, not evidence that bodily sensations have been fabricated.
In illness anxiety, structured CBT, exposure-based approaches, and related psychological interventions may help people respond differently to uncertainty and reduce compulsive checking or reassurance cycles. A 2026 network meta-analysis of randomized trials identified benefit for several psychological approaches, although trial quality, treatment comparisons, and follow-up duration limit firm rankings among them. Treatment should incorporate appropriate medical care, especially when an illness is genuinely present. [2026 health anxiety treatment review] [Published English Hub article on anxiety-related physical symptoms]
Trials across persistent physical symptoms and bodily distress suggest that psychological treatment can improve distress and functioning, often with modest average effects and substantial variability. Recent meta-analyses of different psychotherapy modalities and internet-delivered CBT add evidence for accessible care but combine heterogeneous diagnostic groups. Results from broadly defined persistent physical symptoms cannot be assumed to apply equally to every DSM SSD case, every FND subtype, or every medically diagnosed chronic condition. [2025 psychotherapy meta-analysis] [2026 internet CBT meta-analysis]
Rehabilitation for functional neurological symptoms
When function is impaired by functional weakness, tremor, or gait disturbance, specialist physiotherapy can use demonstrations of preserved movement, redirected attention, goal-directed activities, and gradual retraining of ordinary movement. Occupational therapy may address pacing, daily activities, school or work modifications, and self-management; speech-language therapy can be appropriate for functional speech and voice difficulties. Rehabilitation is tailored to the neurological presentation and should consider pain, fatigue, falls risk, and comorbid disease.
Expert consensus supports physiotherapy principles for functional motor disorders, while randomized trial results require careful interpretation. In the 2024 Physio4FMD trial, specialist physiotherapy did not significantly improve the primary physical-functioning outcome over control at 12 months, though several secondary outcomes favored the intervention. Thus there is a clinical basis for individualized rehabilitation and encouraging functional progress, alongside unresolved questions about which programs work best for whom and how durable benefits are. [Physiotherapy consensus] [Physio4FMD randomized trial]
Treatment and safety planning for functional seizures
Functional seizure care begins with a clearly communicated diagnosis, clinical assessment of event types, and practical discussion of safety and functioning. Based on its systematic review, the 2026 AAN guideline found that psychological interventions are possibly effective for reducing seizure frequency, increasing freedom from events, and improving selected psychosocial outcomes. The evidence is not uniform, and clinicians should review the person's circumstances rather than promise a particular outcome.
The large CODES randomized trial found improvements in several secondary psychosocial outcomes after dissociative-seizure-specific CBT plus standardized medical care, but its primary outcome of monthly seizure frequency at 12 months did not differ significantly from standardized care alone. This distinction matters when patients are deciding what treatment can realistically achieve. Coexisting epilepsy must continue to receive appropriate treatment, and treatment changes involving antiseizure medicines require a physician-supervised plan. [AAN functional seizure guideline] [CODES randomized controlled trial]
Safety guidance is individualized. The treating neurologist can advise on bathing, heights, operating machinery, driving restrictions under local law, when caregivers should request emergency help, and how to distinguish the person's usual episodes from a new or prolonged event. Generic instructions designed for epileptic seizures are not automatically sufficient for every functional presentation. A written plan shared with family and relevant professionals can reduce confusion and avoid unnecessary interventions.
Medication and medical management
There is no single medication that has been established to directly reverse SSD, IAD, FND, or all functional seizures. Medicines may be indicated for a coexisting depressive or anxiety disorder, chronic pain condition, sleep problem, epilepsy, or other diagnosed illness. Clinicians review potential benefit, adverse effects, drug interactions, and how medications affect fatigue or cognition. Functional symptoms must not be used to dismiss the benefits of necessary disease-specific treatment.
Patients should discuss medication changes with the prescribing clinician. This is especially important for benzodiazepines, antiseizure drugs, antidepressants, and medicines requiring gradual reduction. Avoiding unnecessary treatment can be beneficial, but it requires a reliable clinical diagnosis, an individualized taper plan when appropriate, and monitoring.
What coordinated rehabilitation looks like
An integrated plan may involve a primary care physician, relevant medical specialists, a neurologist, a psychologist or psychiatrist, physiotherapist, occupational therapist, speech-language therapist, and social or educational supports. Team members should use a consistent diagnostic explanation while retaining their particular responsibilities. A schedule for reviewing symptoms, functional milestones, adverse effects, and new warning signs helps keep treatment coherent.
When specialist services are unavailable, clinicians can still establish goals, provide evidence-based explanations, address coexisting conditions, and arrange follow-up or remote psychological treatment where suitable. Accessibility, language, insurance, transportation, disability accommodations, and the patient's preference for treatment format affect whether an intervention is realistically usable. These practical barriers are part of good care planning, not evidence of poor motivation.
Children and adolescents
Children and teenagers can develop significant persistent physical symptoms, health anxiety, or functional neurological symptoms, and their evaluation must fit developmental stage. Medical and neurological differentials include pediatric-specific conditions, medication effects, sleep disruption, and learning or neurodevelopmental needs. A child's inability to articulate a symptom clearly is not grounds for assuming deception or purely emotional causation. Clinicians should communicate directly with the child in language they can understand and involve caregivers appropriately.
Family responses, school attendance, peer relationships, activity patterns, and accommodations can influence disability and recovery. Care may involve pediatricians, child mental health clinicians, neurologists, rehabilitation teams, caregivers, and the school. Supportive return-to-school planning should be graded to the child's functional capacity and safety, with attention to bullying, learning barriers, and social isolation. Clinical guidance emphasizes family-centered explanation and coordinated functional restoration while retaining appropriate medical reassessment. [Canadian Paediatric Society guidance]
For adolescents with functional seizures or motor symptoms, disclosure of the diagnosis should be compassionate and concrete. Family members can learn what happens during usual events, recognize medical changes requiring urgent care, and reinforce agreed treatment goals. Programs should avoid blaming the child or parent and should adapt treatment when there is comorbid depression, anxiety, neurological disease, or unmet social needs.
Prognosis, recovery, and ongoing follow-up
The course varies greatly among individuals and diagnostic groups. Some symptoms improve after a clear explanation and coordinated care; others remain persistent or fluctuate for years, especially when disability, comorbidity, fragmented treatment, or major barriers to rehabilitation continue. Improvement may involve reduced symptom burden, better activity tolerance, fewer emergency visits, stronger social participation, or better quality of life. A return to meaningful functioning is a valuable outcome even when a symptom remains.
Evidence for long-term outcomes is uneven across conditions. Some treatment trials have short follow-up, recruit selected patients, or define different outcomes. Small average effect sizes do not predict a particular individual's response, and positive uncontrolled case series may overestimate benefit. For FND, more research is needed on prognostic markers, scalable rehabilitation, patient-reported priorities, and mechanisms underlying treatment response. [2025 FND review] [2026 treatment review]
Ongoing follow-up also protects diagnostic accuracy. A previously appropriate SSD or FND diagnosis can remain clinically useful while a new infection, neurological syndrome, endocrine problem, medication reaction, or other illness receives evaluation. Recurrence of familiar symptoms does not remove the need to investigate a materially different or rapidly progressing presentation.
When to seek immediate medical help
Seek emergency medical assessment for sudden new weakness or one-sided facial changes, new trouble speaking, acute confusion, severe or unusual headache, difficulty breathing, severe chest pain, major injury, or seizure-like activity that is prolonged, different from the person's usual episodes, or accompanied by concerning loss of breathing or recovery. Emergency recommendations depend on local services, medical history, and the patient's individualized seizure or FND plan. A known functional diagnosis never makes these symptoms automatically safe.
For nonemergency but concerning developments, contact a clinician when symptoms are changing, previously tolerable activities become impossible, treatment causes adverse effects, health worries dominate daily life, or there is significant depression or hopelessness. New medical findings and the person's own account should be considered as part of continuing care.
Common misconceptions and clinical distinctions
Are the symptoms real when tests are normal?
Yes. Patients can experience disabling pain, weakness, nausea, dizziness, fatigue, tremors, or seizure-like episodes even if a particular investigation reveals no structural explanation. The relevant question is what a test can detect and whether the appropriate clinical criteria for a particular disorder are met. Negative tests are neither proof of deception nor, by themselves, proof of FND.
Does stress cause every functional symptom?
No universal stress mechanism has been established. Stressful events and trauma can contribute in some cases, and clinicians should ask about them sensitively when relevant. Other patients report injury, illness, physiological triggers, or no recognizable trigger. A person can have FND without a trauma history and can have trauma without FND. A causal formulation requires individualized evidence.
Can someone have an organic neurological disease and FND together?
Yes. Functional symptoms may coexist with epilepsy, migraine, movement disorders, or other neurological and medical illnesses. Clinicians evaluate each relevant symptom and event type. Coexistence is especially important for seizure-like episodes because some patients experience both epileptic and functional seizures. [AAN guideline on concurrent epilepsy]
Is a high PHQ-15 or health-anxiety score a diagnosis?
No. Questionnaires quantify symptom frequency, severity, or worry. Their interpretation depends on validation setting, purpose, other medical conditions, and clinical interview. A scale cannot prove SSD, IAD, intentional deception, or the cause of a neurological symptom.
Is 'medically unexplained symptoms' a medical diagnosis?
The expression describes a state of clinical explanation and has been used variably across specialties. It is neither an adequate final diagnosis for every patient nor interchangeable with FND or SSD. A 2026 umbrella review found extensive inconsistency in terminology across systematic reviews, underlining the importance of naming the specific diagnosis and classification when known. [2026 terminology umbrella review]
Practical steps for patients and families
A useful approach is to keep a concise symptom timeline, bring medication and diagnosis lists to appointments, ask which positive clinical findings support the diagnosis, and clarify what further testing is appropriate. Patients can request a written plan naming the lead clinician, specific rehabilitation or psychological options, measures of meaningful improvement, and the circumstances that require urgent reassessment. Shared goals can include school attendance, mobility, sleep, work, or daily independence.
When there is persistent worry about serious disease, a clinician or therapist can help distinguish scheduled medically indicated review from repetitive checking that perpetuates anxiety. Where functional movement or seizure-like symptoms are present, the plan should come from the relevant specialists. Families can help by taking symptoms seriously, supporting the agreed plan, and avoiding unsupported assumptions about the patient's intentions.
Frequently asked questions
What is the difference between somatic symptom disorder and FND?
Somatic symptom disorder focuses on distressing physical symptoms together with excessive symptom-related thinking, feeling, or behavior under DSM criteria. Functional neurological disorder concerns a motor or sensory neurological presentation demonstrated by appropriate positive clinical findings. A person may meet criteria for one, both, or neither.
Is somatic symptom disorder the same as psychosomatic illness?
No. 'Psychosomatic' is a broad and inconsistently used description of interactions between psychological and bodily processes. SSD is a specific DSM-5-TR diagnosis. The latter requires its own criteria and may coexist with medical disease. The general stress–health relationship is a broader topic than this clinical classification.
What is the difference between illness anxiety disorder and SSD?
Illness anxiety disorder centers on fear of having or acquiring serious illness with absent or mild somatic symptoms. SSD involves one or more distressing bodily symptoms and excessive responses to them. The distinction requires a complete clinical assessment, especially when anxiety, OCD, panic, or actual illness coexists.
Can illness anxiety occur when someone has a real medical condition?
Yes. Concerns about diagnosed disease can be proportionate, or health-related fears and behaviors can become unusually persistent and impairing. Whether an additional clinical diagnosis applies requires assessing the intensity, context, symptoms, and differential diagnoses rather than using the medical condition as proof for or against it.
Can functional seizures and epileptic seizures occur in the same person?
Yes. Co-occurrence is recognized in neurological practice. A history, witness reports, video recordings, and video-EEG when indicated help clinicians determine episode types. Treatment for diagnosed epilepsy should continue or change only under specialist guidance.
Does normal MRI or EEG prove FND?
No. FND is a positive clinical diagnosis based on appropriate examination or event characteristics and evaluation of alternatives. MRI may be normal in many illnesses; EEG has specific limits and depends on what was recorded. Neurologists interpret each test in its clinical context.
Are functional symptoms consciously controlled?
FND is diagnosed without presuming voluntary production of symptoms. Clinically observed variation with attention or task context can be a positive sign of how nervous-system functioning changes; it is not evidence that the person is choosing the symptom. Intentional falsification requires independent assessment under a different framework.
Does everyone with FND need trauma therapy?
No. Trauma-focused treatment is relevant when someone has a separately assessed trauma-related condition or when the person's clinical formulation supports such treatment. FND care is individualized and may emphasize neurological rehabilitation, functional seizure psychotherapy, sleep, pain management, or other needs.
What treatments work best?
There is no single best treatment across these diagnoses. CBT has evidence for several symptom-distress and illness-anxiety problems; symptom-specific physiotherapy and related therapies can be offered for functional motor symptoms; psychologically informed treatment may benefit functional seizures. The magnitude and certainty of benefits depend on the diagnosis, intervention, and outcome. Coordinated medical follow-up remains essential.
Are medications always necessary?
No. Medication decisions depend on diagnosed coexisting conditions and the risks and benefits of specific drugs. An SSRI might be considered for a separate anxiety or depressive disorder; antiseizure drugs are used when epilepsy or another recognized indication exists. Medication should only be started, reduced, or stopped with an appropriate clinician.
Can children have somatic symptom disorder or FND?
Yes. Children and adolescents can have clinically significant somatic or functional presentations. Evaluation considers growth and development, medical conditions, family and school environments, age-appropriate communication, and pediatric specialist input when indicated.
Will these conditions improve?
Many people experience improvement, although the trajectory differs substantially. Treatment may reduce symptom intensity, fear, care disruption, or disability and may restore participation. Continued symptoms or setbacks warrant a review of the plan and relevant medical differentials rather than an assumption of failure or intentional symptom production.
In-depth clinical guides
For detailed classification and treatment of bodily distress, read Somatic Symptom Disorder: Symptoms, Diagnosis, and Treatment, Somatic Symptom Disorder With a Medical Condition, and Somatic Symptom Disorder Treatment: CBT and Coordinated Medical Care.
The illness-preoccupation pathway is explained in Illness Anxiety Disorder: Symptoms, Diagnosis, and Treatment, Health Anxiety: Signs, Triggers, and When It Becomes a Disorder, and Illness Anxiety Disorder Treatment: CBT, Exposure, and Follow-Up Care.
For neurological signs and treatment decisions, consult Functional Neurological Disorder Diagnosis: Positive Signs and Medical Assessment, Functional Neurological Disorder Symptoms: Movement, Sensation, and Seizures, and Functional Neurological Disorder Treatment: Rehabilitation and Psychological Care.
For seizure-like episodes, see Functional Seizures (PNES): Symptoms, Diagnosis, and Treatment and Functional Seizures vs Epileptic Seizures: How Clinicians Distinguish Them. These separate guides expand the clinical intent without reusing this article's overview as a replacement.
Related Articles
Readers exploring overlapping experiences may find the Hub's already-published English discussions of symptom physiology, anxiety, and differential diagnosis useful. These articles address neighboring intents and do not replace condition-specific medical evaluation. [Physical symptoms of anxiety] [OCD versus illness anxiety disorder] [Panic attack versus seizure] [Historical conversion neurosis]
References
American Academy of Neurology / Tolchin B, et al. (2026). Management of functional seizures practice guideline executive summary. Neurology, 106(1), e214466. DOI: 10.1212/WNL.0000000000214466. [Source]
American Psychiatric Association. (2022). Somatic symptom and related disorders. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). DOI: 10.1176/appi.books.9780890425787.x09_Somatic_Symptom_and_Related_Disorders. [Source]
Aybek S, Perez DL. (2022). Diagnosis and management of functional neurological disorder. BMJ, 376, o64. [Source]
Cabreira V, et al. (2023). Clinical signs in functional cognitive disorders: A systematic review and diagnostic meta-analysis. Journal of Psychosomatic Research. DOI: 10.1016/j.jpsychores.2023.111447. [Source]
Cabreira V, et al. (2025). Perspectives on diagnosis and management of functional cognitive disorder: An international Delphi study. European Journal of Neurology. DOI: 10.1111/ene.16318. [Source]
Canadian Paediatric Society. (2024). Somatic symptom and related disorders: Guidance on assessment and management. [Source]
Dworetzky BA, Baslet G. (2025). Functional neurological disorder: Practical management. Neurotherapeutics. DOI: 10.1016/j.neurot.2025.e00612. [Source]
Goldstein LH, et al. (2020). Cognitive behavioural therapy for adults with dissociative seizures (CODES): A pragmatic, multicentre, randomised controlled trial. The Lancet Psychiatry. [Source]
Gureje O, et al. (2025). The epidemiology of ICD-11 bodily distress disorder and DSM-5 somatic symptom disorder in new large-scale population surveys within the World Mental Health Survey Initiative. World Psychiatry, 24, 395–403. DOI: 10.1002/wps.21353. [Source]
Lai L, et al. (2026). The comparative effectiveness of psychological interventions for health anxiety: Systematic review and network meta-analysis of randomized controlled trials. British Journal of Psychiatry. DOI: 10.1192/bjp.2026.10647. [Source]
Liu S, et al. (2026). Efficacy of internet-based cognitive behavioral therapy on somatic symptom disorder and common related functional disorders: A meta-analysis of randomized controlled trials. General Hospital Psychiatry, 99, 92–101. DOI: 10.1016/j.genhosppsych.2026.01.017. [Source]
Löwe B, et al. (2024). Persistent physical symptoms: Definition, genesis, and management. The Lancet, 403, 2649–2662. DOI: 10.1016/S0140-6736(24)00623-8. [Source]
Maas genannt Bermpohl F, Martin A. (2025). Efficacy of cognitive behavioral therapy and acceptance- and mindfulness-based treatments in adults with bodily distress: A network meta-analysis. Psychotherapy and Psychosomatics, 94, 207–224. DOI: 10.1159/000544825. [Source]
Medically unexplained symptoms: A systematic umbrella review of current terminology and reported rationales. (2026). PubMed PMID: 42178866. [Source]
Nielsen G, et al. (2024). Specialist physiotherapy for functional motor disorder (Physio4FMD): Randomised controlled trial. The Lancet Neurology. DOI: 10.1016/S1474-4422(24)00135-2. [Source]
Park JE. (2026). Treatment of functional neurological disorders. Journal of Clinical Neurology. DOI: 10.3988/jcn.2026.0223. [Source]
Physiotherapy for functional motor disorders: A consensus recommendation. (2015). Journal of Neurology, Neurosurgery & Psychiatry. [Source]
World Health Organization. (2024). Clinical descriptions and diagnostic requirements for ICD-11 mental, behavioural and neurodevelopmental disorders. [Source]
Editorial scope: This article provides educational information about diagnostic categories and evidence-based care; it does not diagnose an individual or replace an examination by a qualified clinician. Evidence and classification references were reviewed for this article in October 2026.